Singelyn F J, Gouverneur J M
Department of Anesthesiology, Université Catholique de Louvain School of Medicine, St. Luc Hospital, Brussels, Belgium.
Anesth Analg. 2000 Jul;91(1):176-80. doi: 10.1097/00000539-200007000-00033.
This prospective, randomized, double-blinded study assessed the efficacy of patient-controlled analgesia (PCA) techniques for extended "3-in-1" block after total knee arthroplasty. A total of 45 patients were divided into three groups of 15. Over 48 h, all patients received 0.125% bupivacaine with 1 microg/mL clonidine via a femoral nerve sheath catheter in the following manner: as a continuous infusion at 10 mL/h in Group 1; as a continuous infusion at 5 mL/h plus PCA boluses (2.5 mL/30 min) in Group 2; or as PCA boluses only (10 mL/60 min) in Group 3. Pain scores, sensory block, supplemental analgesia, bupivacaine consumption, side effects, and satisfaction scores were recorded. Pain scores and supplemental analgesia were comparable in the three groups. Bupivacaine consumption was significantly less in Groups 2 and 3 than in Group 1 (P < 0.01), and in Group 3 than in Group 2 (P < 0.01). Side effects and satisfaction were comparable in the three groups. We conclude that extended "3-in-1" block provides efficient pain relief after total knee arthroplasty and that, compared with a continuous infusion, PCA techniques reduce the local anesthetic consumption without compromise in patient satisfaction or visual analog scale scores. Of the two PCA techniques tested, PCA boluses (10-mL lockout; time, 60 min) of 0.125% bupivacaine with 1 microg/mL clonidine was associated with the smallest local anesthetic consumption, and is, therefore, the recommended extended "3-in-1" block technique.
We demonstrated that, after total knee arthroplasty, an extended "3-in-1" block consisting of patient-controlled analgesia boluses (10 mL/60 min) of 0.125% bupivacaine with 1 microg/mL clonidine provides efficient postoperative analgesia and significantly minimizes local anesthetic consumption.
这项前瞻性、随机、双盲研究评估了全膝关节置换术后患者自控镇痛(PCA)技术用于延长“三合一”阻滞的疗效。共45例患者被分为三组,每组15例。在48小时内,所有患者通过股神经鞘导管以下列方式接受含1微克/毫升可乐定的0.125%布比卡因:第1组以10毫升/小时的速度持续输注;第2组以5毫升/小时的速度持续输注加PCA推注(2.5毫升/30分钟);第3组仅采用PCA推注(10毫升/60分钟)。记录疼痛评分、感觉阻滞、补充镇痛、布比卡因用量、副作用和满意度评分。三组的疼痛评分和补充镇痛情况相当。第2组和第3组的布比卡因用量显著少于第1组(P<0.01),且第3组少于第2组(P<0.01)。三组的副作用和满意度相当。我们得出结论,延长“三合一”阻滞在全膝关节置换术后可提供有效的疼痛缓解,并且与持续输注相比,PCA技术可减少局部麻醉药用量,而不会影响患者满意度或视觉模拟评分。在所测试的两种PCA技术中,含1微克/毫升可乐定的0.125%布比卡因的PCA推注(锁定量10毫升;时间60分钟)与局部麻醉药用量最少相关,因此是推荐的延长“三合一”阻滞技术。
我们证明,全膝关节置换术后,由含1微克/毫升可乐定的0.125%布比卡因的患者自控镇痛推注(10毫升/60分钟)组成的延长“三合一”阻滞可提供有效的术后镇痛,并显著减少局部麻醉药用量。